TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-28 5:57 pm Sale |
2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
TAKEDA PHARMACEUTICAL CO LTD | 87,258 0.300% |
-2,592,544 (-96.74%) |
Filing |